Huiyu Pharmaceutical (688553.SH): Injection solutions of tramadol and docetaxel have obtained marketing approval in France and Egypt respectively.

10/01/2025

GMT Eight

Huiyu Pharmaceutical (688553.SH) announced that its wholly-owned subsidiary, Seacross Pharmaceuticals Ltd., has recently received approval from the French National Agency for the Safety of Medicines and Health Products, and the Egyptian Drug Authority, for the marketing authorization of the company's products injection Tocilizumab and injection of Docetaxel.

Hefei I-TEK OptoElectronics (688610.SH): 16.21 million restricted shares will be listed for trading on January 20, accounting for 23.84% of the total share capital.

The IMF acknowledges Hong Kong's status and role as an international financial center and expects its fiscal deficit to narrow.

Contact: contact@gmteight.com

Huiyu Pharmaceutical (688553.SH): Injection solutions of tramadol and docetaxel have obtained marketing approval in France and Egypt respectively.

RECOMMEND

Chengdu Lihang Technology (603261.SH) 51.20746 million restricted shares will be listed and traded starting from March 17th.

SHANDONG MOLONG(00568): The debtor's bankruptcy liquidation application has been approved.

Yifan Pharmaceutical (002019.SZ): Ambroxol Oral Solution Obtains Drug Registration Certificate.